Company page
Bavarian Nordic A/s
Bavarian Nordic A/S is a public company based in Denmark, trading under the ticker BAVA. The company has a market capitalization of approximately 2.17 billion USD. Bavarian Nordic focuses on developing innovative vaccines and immunotherapies for infectious diseases and cancer.
- Ticker
- BAVA:OMXCOP
- Asset type
- Stock
- Market cap
- $2.17B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- OMXCOP
- Currency
- DKK